Us Bancorp \De\ Edwards Lifesciences Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 707,731 shares of EW stock, worth $52.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

707,731

Previous 744,146 4.89%

Holding current value

$52.9 Million

Previous $68.7 Million 32.05%

% of portfolio

0.06%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$59.7 - $93.78 $2.17 Million - $3.41 Million	-36,415 Reduced 4.89%	707,731 $46.7 Million
Q2 2024 Aug 06, 2024	SELL	$84.3 - $94.31 $1.54 Million - $1.73 Million	-18,321 Reduced 2.4%	744,146 $68.7 Million
Q1 2024 May 07, 2024	SELL	$72.54 - $95.56 $4.74 Million - $6.25 Million	-65,373 Reduced 7.9%	762,467 $72.9 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $1.38 Million - $1.74 Million	-22,417 Reduced 2.64%	827,840 $63.1 Million
Q3 2023 Nov 03, 2023	BUY	$69.28 - $93.38 $374,735 - $505,092	5,409 Added 0.64%	850,257 $58.9 Million
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $598,770 - $693,797	-7,355 Reduced 0.86%	844,848 $79.7 Million
Q1 2023 May 09, 2023	SELL	$74.26 - $84.51 $77,378 - $88,059	-1,042 Reduced 0.12%	852,203 $70.5 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $7.11 Million - $9.1 Million	104,052 Added 13.89%	853,245 $63.7 Million
Q3 2022 Oct 27, 2022	SELL	$82.37 - $107.29 $1.6 Million - $2.09 Million	-19,454 Reduced 2.53%	749,193 $61.9 Million
Q2 2022 Aug 01, 2022	BUY	$86.5 - $128.27 $1.71 Million - $2.53 Million	19,743 Added 2.64%	768,647 $73.1 Million
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $3.95 Million - $4.98 Million	38,770 Added 5.46%	748,904 $88.2 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $582,269 - $715,342	5,474 Added 0.78%	710,134 $92 Million
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $2.81 Million - $3.35 Million	-27,280 Reduced 3.73%	704,660 $79.8 Million
Q2 2021 Aug 05, 2021	SELL	$83.84 - $104.76 $32,026 - $40,018	-382 Reduced 0.05%	731,940 $75.8 Million
Q1 2021 Apr 28, 2021	BUY	$78.68 - $90.67 $881,766 - $1.02 Million	11,207 Added 1.55%	732,322 $61.3 Million
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $1.7 Million - $2.16 Million	23,718 Added 3.4%	721,115 $65.8 Million
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $2.33 Million - $3.03 Million	-34,658 Reduced 4.73%	697,397 $55.7 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $28.6 Million - $38.2 Million	496,739 Added 211.09%	732,055 $50.6 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $402,561 - $622,161	-7,681 Reduced 3.16%	235,316 $44.4 Million
Q4 2019 Feb 04, 2020	SELL	$71.7 - $82.09 $1.25 Million - $1.43 Million	-17,476 Reduced 6.71%	242,997 $56.7 Million
Q3 2019 Nov 08, 2019	SELL	$61.55 - $75.43 $919,310 - $1.13 Million	-14,936 Reduced 5.42%	260,473 $57.3 Million
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $544,412 - $629,092	-9,767 Reduced 3.42%	275,409 $50.9 Million
Q1 2019 May 08, 2019	SELL	$47.89 - $64.05 $275,415 - $368,351	-5,751 Reduced 1.98%	285,176 $54.6 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $322,781 - $396,017	-6,955 Reduced 2.33%	290,927 $44.6 Million
Q3 2018 Nov 01, 2018	SELL	$45.7 - $58.03 $784,486 - $996,142	-17,166 Reduced 5.45%	297,882 $51.9 Million
Q2 2018 Aug 08, 2018	SELL	$42.45 - $51.3 $714,518 - $863,481	-16,832 Reduced 5.07%	315,048 $45.9 Million
Q1 2018 May 08, 2018	SELL	$37.19 - $47.45 $388,152 - $495,235	-10,437 Reduced 3.05%	331,880 $46.3 Million
Q4 2017 Feb 02, 2018	BUY	$33.79 - $39.39 $2.19 Million - $2.55 Million	64,677 Added 23.3%	342,317 $38.6 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $10.1 Million - $10.8 Million	277,640	277,640 $30.4 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account